Phase IIb study to evaluate the safety and efficacy of topical difluoromethylornithine [eflornithine] and topical diclofenac in the treatment of sun-damaged skin on the forearm
Latest Information Update: 17 Sep 2021
Price :
$35 *
At a glance
- Drugs Diclofenac/hyaluronic-acid (Primary) ; Eflornithine (Primary)
- Indications Skin cancer
- Focus Therapeutic Use
- 28 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Mar 2007 New trial record.